Home › Core › ISCC-IDs › 28C8B3F4ZEqtH

View ISCC-ID

Core Data

28C8B3F4ZEqtH
ISCC-ID - digital asset identifier
CCLaB3T567iTv-CTKH1gW2JpQEE-CDPz6khZuGZD2-CRFNXQc2CPYXU
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

development of rituximabresistant lymphoma clones with altered cell signaling and crossresistance to chemotherapy

Ledger Reference

coblo
Source Ledger/Blockchain
12409522
N-th ISCC Decleration on source ledger
4959994ac1431fa85d38ea519efb4b1c73eb0b41e13a576130e5cc3b36dd8672
Hash of block that includes the ISCC-DECLARATION
c33fdfe08ad7541d43eb950d5f16d554d4f3a8eb063011f2b1c366615e0d68fa
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Development of Rituximab-Resistant Lymphoma Clones with Altered Cell Signaling and Cross-Resistance to Chemotherapy", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Ali R. Jazirehi", "@type": "Person"}, {"name": "Mario I. Vega", "@type": "Person"}, {"name": "Benjamin Bonavida", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://pdfs.semanticscholar.org/e7fe/a93b43a48224a9b0c5535d3644cc44bd9bdb.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Association for Cancer Research (AACR)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1158/0008-5472.can-06-2184", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCLaB3T567iTv-CTKH1gW2JpQEE-CDPz6khZuGZD2-CRFNXQc2CPYXU", "propertyID": "ISCC"}], "datePublished": "2007-02-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close